Skip to content
Independent investment research since 1991 Linden, New Jersey · 908-975-0250
Lark Research High Quality Independent Investment Research

Risk/Reward archive

OGN stock research

April 2, 2025Health Care · OGN

Organon (OGN) 24Q4 Update

24Q4 revenues were $1.59 billion, up 3% at constant currency but down 0.4% YOY and 2.8% below my estimate.  GAAP diluted EPS was $0.42, compared with 23Q4’s $2.13 and my estimate of $0.60.  Non-GAAP EPS of $0.90 was…

Continue reading →